🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a multinational, randomised, double-blind, placebo-controlled, par...
Status
Completed
Location
Multiple Locations
Start Date
2009-04
Trial ID
NCT01820559
Treatments Being Tested
The purpose of this study is to determine the effects of age on the pharmac...
Status
Completed
Location
Scope International Life Sciences AG,
Start Date
2002-06
Trial ID
NCT02172755
Treatments Being Tested
The primary objective of the study is to assess the efficacy of eslicarbaze...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00981227
Treatments Being Tested
Multicentre, double-blind, randomised, parallel-group, placebo-controlled d...
Status
Completed
Location
Multiple Locations
Start Date
2005-12
Trial ID
NCT01822678
Treatments Being Tested
This is an 18-week, double-blind, multicenter study with gradual conversion...
Status
Completed
Location
University of Arizona Health Sciences Center
Start Date
2010-06
Trial ID
NCT01091662
Treatments Being Tested
The purpose of this study is to characterize the pharmacokinetics of Eslica...
Status
Completed
Location
Clinica de Neurologie Pediatrica, Spitalul "Alexandru Obregia"
Start Date
2005-06
Trial ID
NCT02170064
Treatments Being Tested
To investigate the pharmacokinetics of a single 900 mg oral dose of BIA 2-0...
Status
Completed
Location
BIAL - Portela & Cª - Human Pharmacology Unit (UFH)
Start Date
2002-03
Trial ID
NCT01678976
Treatments Being Tested
Single centre, open-label, multiple doses, one-sequence design study in two...
Status
Completed
Location
Multiple Locations
Start Date
2007-01
Trial ID
NCT02283814
The primary objective of the study is to assess the efficacy of eslicarbaze...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00980746
Treatments Being Tested
Single centre, double-blind, randomised, placebo-controlled study of two do...
Status
Completed
Location
Human Pharmacology Unit - BIAL - Portela & Ca, S.A.
Start Date
2004-10
Trial ID
NCT01879345
Treatments Being Tested